Global Pre-packed Chromatography Columns Market 2016-2020
Chromatography is a technique used for the purification of specific chemical compounds from mixtures of compounds. Pre-packed chromatography columns refer to the pre-filled columns used in chromatography testing procedures. The columns constitute a key component, along with instruments and other consumables.
Technavio’s analysts forecast the global pre-packed chromatography columns market to grow at a CAGR of 8.02% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pre-packed chromatography columns market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of various sizes of pre-packed columns to end-markets.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Pre-Packed Chromatography Columns Market 2016-2020
Technavio recognizes the following companies as the key players in the global pre-packed chromatography columns market: EMD Millipore, GE Healthcare, Repligen, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PALL, Phenomenex, Sigma Aldrich, Shimadzu, Tosoh, and Waters.
Commenting on the report, an analyst from Technavio’s team said: “One of the key trends for market growth will be rise in healthcare costs. Healthcare costs have been rising over the past decade. In the US, they increased by 91% between 2000 and 2011. There has also been a significant rise in the number of diseases, especially cancer. Pre-packed chromatography columns are used by diagnostic centers to conduct metabolic profiling for the identification of cancer, which is a leading cause of deaths worldwide.”
According to the report, increased demand in pharmaceutical industry will be a key driver for market growth. A growing number of pharmaceutical companies worldwide are using chromatography for developing a wide variety of drugs indicated for various diseases and medical conditions. The use of chromatography columns has significantly increased in the biopharmaceutical industry as the purification of biopharmaceuticals is considered a major bottleneck during the manufacturing process. Technological advances in liquid chromatography have enabled biopharmaceutical companies to overcome this bottleneck by providing an easy way to determine and measure properties and interactions better in terms of the composition of the mixture, the solutes' molecular properties, and their interaction with the resins, which is the key for experimentation.
Further, the report states that there are different types of resins used in pre-packed chromatography columns. They are mostly very expensive, and they are intended for single use. Compared with conventional chromatography columns, pre-packed chromatography columns are not limited in terms of sizes available in the market. Some vendors have limitations such as resin type, packed-bed height, and column diameter, which are the major causes for concern while making purchase decisions. A key factor hampering the utilization of pre-packed chromatography solutions is the high cost of solutions as a result of high development and approval costs. Therefore, selectivity and efficiency factors play a major role in purchase decisions. In addition, the complexity involved in the manufacture of pre-packed chromatography columns due to the use of a variety of materials to create the product is also a major challenge.
EMD Millipore, GE Healthcare, Repligen, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PALL, Phenomenex, Sigma Aldrich, Shimadzu, Tosoh, and Waters.